Tricia A. Bentz

A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors

Carolyn D. Britten, Elizabeth Garrett‐Mayer, Steven Chin et al. · Clinical Cancer Research · 2017 · 165 citations · Full text

Medicine, Oncology, Pharmacology +11

A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma

Melanie B. Thomas, Elizabeth Garrett‐Mayer, Munazza Anis et al. · Oncology · 2018 · 48 citations · Full text

Medicine, Oncology, Pharmacology +12

Patient participation in cancer clinical trials: A pilot test of lay navigation

Kathleen B. Cartmell, Heather Shaw Bonilha, Terri Matson et al. · Contemporary Clinical Trials Communications · 2016 · 33 citations · Full text

Medicine, Oncology, Radiology +17

Sequential ofatumumab and lenalidomide for the treatment of relapsed and refractory chronic lymphocytic leukemia and small lymphocytic lymphoma

Luciano J. Costa, Suzanne Fanning, Joe Stephenson et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 31 citations

Medicine, Oncology, Pharmacology +17

Clinical Trial Metrics: The Complexity of Conducting Clinical Trials in North American Cancer Centers

Carrie B. Lee, Theresa L. Werner, Allison M. Deal et al. · JCO Oncology Practice · 2020 · 16 citations · Full text

Medicine, Health Administration, Oncology +17